The ongoing Intel–U.S. government deal marks a major policy shift, boosting domestic chipmaking with funding and equity while limiting Intel’s strategic flexibility and independence.
Browsing: CHIPS and Science Act
The Trump administration is weighing a historic move to take a 10% stake in Intel, converting CHIPS Act grants into equity to secure U.S. semiconductor manufacturing.
Trump’s 100% semiconductor import tariff, with exemptions for U.S. investors, marks a bold industrial shift to boost domestic chip manufacturing and tech self-reliance.
Indian American economist to coordinate implementation of CHIPS and Science Act to give the US a competitive edge